ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals Revenue

In the year 2023, ANI Pharmaceuticals had annual revenue of $486.82M with 53.87% growth. Revenue in the quarter ending December 31, 2023 was $131.65M with 39.71% year-over-year growth.

• Revenue (ttm): $486.82M
• Revenue Growth: +53.87%
• P/S Ratio: 2.91
• Revenue / Employee: $758,280
• Employees: 642
• Market Cap: 1.41B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	486.82M	170.43M	53.87%
Dec 31, 2022	316.39M	100.25M	46.38%
Dec 31, 2021	216.14M	7.66M	3.67%
Dec 31, 2020	208.48M	1.93M	0.93%
Dec 31, 2019	206.55M	4.97M	2.47%
Dec 31, 2018	201.58M	24.73M	13.99%
Dec 31, 2017	176.84M	48.22M	37.49%
Dec 31, 2016	128.62M	52.30M	68.53%
Dec 31, 2015	76.32M	20.35M	36.36%
Dec 31, 2014	55.97M	25.89M	86.06%
Dec 31, 2013	30.08M	27.78M	1,207.49%
Dec 31, 2012	2.30M	1.87M	428.71%
Dec 31, 2011	435.16K	-2.04M	-82.41%
Dec 31, 2010	2.47M	1.22M	96.67%
Dec 31, 2009	1.26M	-2.52M	-66.73%
Dec 31, 2008	3.78M	3.29M	666.82%
Dec 31, 2007	493.05K	-13.94M	-96.59%
Dec 31, 2006	14.44M	14.18M	5,496.12%
Dec 31, 2005	258.00K	180.00K	230.77%
Dec 31, 2004	78.00K	12.51K	19.09%
Dec 31, 2003	65.49K	-2.70M	-97.64%
Dec 31, 2002	2.77M	1.02M	58.53%
Dec 31, 2001	1.75M	1.52M	667.35%
Dec 31, 2000	227.72K	29.04K	14.61%
Dec 31, 1999	198.68K	-	-
Dec 31, 1998	0	-	-
Dec 31, 1997	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.